Drawing blood from an implanted port follows a specific sequence: clean the skin, access the port with a non-coring needle, discard a set volume of blood to clear the line, collect your specimens, then flush and lock the catheter. Each step has pitfalls that can contaminate samples, introduce infection, or damage the device. The procedure is routine once learned, but the details matter more than they might seem, particularly when certain lab tests are ordered or when the port resists giving blood back.
Preparing the Skin and Accessing the Port
Before the needle goes in, the skin over the port reservoir needs thorough antiseptic preparation. The standard recommendation is 2% chlorhexidine gluconate in 70% isopropyl alcohol, applied in a back-and-forth scrubbing motion and allowed to dry completely. A narrative review of catheter-related infection prevention found this combination to be the most effective strategy for reducing catheter-related infections, though povidone-iodine remains a reasonable alternative for patients who cannot tolerate chlorhexidine or in settings where chlorhexidine is unavailable.1PubMed. Chlorhexidine and povidone-iodine: Unmasking the unknown in catheter-related infection prevention, a narrative review Letting the antiseptic air-dry is not optional; wiping it off early reduces its effectiveness and can introduce stinging when the needle punctures the skin.
The needle used to access a port is a non-coring (Huber point) needle, which has a deflected tip designed to slice through the port’s silicone septum without punching out a core of material. A standard hypodermic needle would gradually destroy the septum over repeated accesses. Huber needles come in straight and right-angle configurations. For a quick blood draw where the needle will be removed right after, either style works, but right-angle needles with attached extension tubing are easier to stabilize and are standard in most facilities. You palpate the edges of the port through the skin, stabilize it between your fingers, and insert the needle perpendicular to the septum until you feel it hit the back wall of the reservoir, a subtle click or firm stop.
The Discard Volume Before Collecting Specimens
Once the needle is seated and you can aspirate blood, the first milliliters drawn are not usable for lab testing. This initial volume, sometimes called the “waste” or “discard,” clears the catheter lumen of whatever flush solution was locked inside, usually saline or dilute heparin. If that fluid mixes with your specimens, it dilutes electrolytes, skews chemistry panels, and can wreak havoc on coagulation studies.
How much to discard has been debated. Many protocols call for 5 mL or more, but a study comparing 3 mL and 5 mL discard volumes found no statistically significant difference in levels of sodium, potassium, calcium, creatinine, total bilirubin, or direct bilirubin between the two groups.2PubMed Central. Performance of 3 mL versus 5 mL Discarded Volume for Blood Sampling from Central Venous Access Device For routine chemistry panels, a 3 mL discard appears sufficient. This matters especially for patients who are already anemic or have low blood volume, since every extra milliliter of discarded blood adds up over repeated draws. Some institutions still mandate larger discard volumes for specific tests, particularly coagulation panels, so check your facility’s policy.
Why Coagulation Tests Need Extra Caution
If the port has been locked with heparin, coagulation studies drawn through it can be falsely prolonged even after what seems like an adequate discard. A retrospective analysis of patients who were not receiving anticoagulant therapy but had abnormally elevated activated partial thromboplastin times (a common clotting test) found that about 39% of those samples returned completely to normal after the heparin was neutralized in the lab.3PubMed. Heparin contamination in coagulation testing and a protocol to avoid it and the risk of inappropriate FFP transfusion In other words, nearly two in five of those alarming results were artifacts of leftover heparin, not real clotting problems. The clinical danger here is that a falsely elevated result could lead to unnecessary transfusions of plasma or delays in surgery.
For this reason, many facilities require a larger discard volume, often 6 mL or even 10 mL, specifically before drawing coagulation tubes from a heparinized line. Some protocols sidestep the issue entirely by drawing coagulation studies from a peripheral vein instead. If a peripheral stick is not an option, the key is to discard generously and to alert the lab that the sample came through a central line so they can interpret results with that context.
Order of Draw and Collecting the Tubes
Once the discard is complete, you collect your tubes in the standard order of draw, just as you would from a peripheral venipuncture. Blood culture bottles go first if ordered, followed by coagulation tubes (light blue top), then serum tubes (red or gold top), then heparin tubes (green top), EDTA tubes (lavender top), and so on. The rationale is to prevent additive carryover from one tube to the next.
When drawing from a port, you typically aspirate blood into a syringe and then transfer it to the tubes, rather than using a vacuum holder directly on the line. The negative pressure from a vacuum tube connected directly to a thin catheter lumen can collapse the catheter walls or cause hemolysis, the rupture of red blood cells. Hemolyzed samples are one of the most common reasons for rejected lab specimens, and central lines are more prone to causing hemolysis than peripheral draws because of the turbulence created when blood is pulled through a narrow lumen. Drawing gently with a syringe gives you more control over the aspiration speed and reduces the shearing forces on the blood cells.
Drawing Blood Cultures From a Port
Blood cultures ordered through a port serve a dual purpose: identifying the organism causing an infection and, sometimes, determining whether the port itself is the source. To figure out whether the catheter is the culprit, clinicians use a technique called differential time to positivity. A set of blood cultures is drawn through the port and a matched set is drawn from a peripheral vein, and both are sent to the lab simultaneously. If the port-drawn cultures turn positive significantly earlier than the peripheral cultures, it strongly suggests the infection is originating from the catheter.
A systematic review and meta-analysis of this technique across over 2,500 suspected catheter-related bloodstream infections found that it had a sensitivity of about 81% and a specificity of roughly 92%, with a cutoff of two hours or more between the port culture turning positive and the peripheral culture turning positive.4PubMed. Utility of Differential Time to Positivity in Diagnosing Central Line-Associated Bloodstream Infections: A Systematic Review and Meta-Analysis Those numbers mean the test is quite good at ruling in a catheter-related infection when the time gap is present, though it can miss some cases. A separate study focusing specifically on fungal infections found similar overall performance but noted that the method was less reliable for certain species of Candida.5PubMed Central. Diagnostic usefulness of differential time to positivity for catheter-related candidemia
The practical takeaway: if blood cultures are ordered and the clinical question is “Is the port infected?”, you need both a port draw and a peripheral draw, labeled clearly with the time and source. Drawing only from the port tells you about the bloodstream infection but not whether the device is the origin.
Flushing and Locking After the Draw
Once all specimens are collected, the port needs to be flushed to clear residual blood from the catheter lumen. Blood left sitting in the line clots, and clots lead to occlusion. The standard flush is 10 to 20 mL of normal saline delivered using a pulsatile, or “push-pause,” technique: short bursts of saline with brief pauses between each push. This creates turbulence inside the lumen that is more effective at sweeping out blood and fibrin than a smooth, continuous push.
After flushing, the port is “locked” with a solution that sits in the catheter between uses. For decades, dilute heparin was the default lock solution. More recently, the evidence has shifted. A systematic review and meta-analysis of eight studies comparing heparin flush to normal saline for maintaining catheter patency found no meaningful advantage for heparin, with a risk ratio that did not reach statistical significance.6PubMed Central. Heparin flush vs. normal saline flush to maintain the patency of central venous catheter among adult patients: A systematic review and meta-analysis A more recent comparative study looking specifically at implanted ports confirmed that when the pulsatile flush technique was used, normal saline appeared to be as effective as heparin in maintaining port patency, with low overall occlusion rates in both groups.7PubMed Central. Normal Saline Push-Pause Advantage for Implanted Port Patency: A Comparative Study
This matters for lab draws because a saline-only lock eliminates the concern about heparin contamination of future specimens. It also simplifies the procedure and removes the small but real risk of heparin-induced thrombocytopenia from repeated low-dose heparin exposure. Many institutions have already switched to saline-only locking for ports, though policies vary.
When the Port Will Not Give Blood Back
One of the most frustrating complications during a port blood draw is persistent withdrawal occlusion: you can flush saline into the port without resistance, but you cannot aspirate blood out. The port works in one direction but not the other. This is not uncommon, and the most frequent cause is a fibrin sheath, a thin sleeve of tissue that forms around the outside of the catheter over time. A study of oncology patients with this problem found that a fibrin sheath was present in 70% of cases.8SAGE Journals (Sci Prog). Aetiology and management of persistent withdrawal occlusion in venous ports in oncology patients
The sheath acts like a one-way valve. When you push fluid in, it flows freely into the vein. When you try to pull blood back, the negative pressure sucks the sheath over the catheter tip, blocking it. Other causes of withdrawal occlusion include the catheter tip being positioned against the vessel wall (positional occlusion), a clot inside the lumen, or, less commonly, the catheter having migrated out of its original position.
Before assuming the port is blocked, try a few positional maneuvers: have the patient raise their arms overhead, take a deep breath and hold it, cough, or roll onto their side. Sometimes just changing the pressure dynamics inside the chest is enough to pull the catheter tip away from the vessel wall. If the port still will not aspirate, the next step is typically a thrombolytic agent.
Clearing a Blocked Port
When positional maneuvers fail, the standard first-line treatment for a thrombotic port occlusion is alteplase, a clot-dissolving drug instilled directly into the catheter. A review of thrombolytic therapies for catheter occlusion reported that alteplase clears about 52% of blocked catheters within 30 minutes, with an overall clearance rate of roughly 86% after a second dose if needed.9PubMed Central. Thrombolytic therapy for central venous catheter occlusion The typical protocol involves instilling a small dose into the port, letting it dwell for 30 minutes, and then attempting aspiration. If the first dose does not work, a second instillation can be tried.
One study of 50 occluded chest ports treated with alteplase achieved 100% restoration of function, with 72% requiring only a single 2 mg dose and 28% needing a second 2 mg dose, and no adverse events were reported.10PubMed Central. Efficacy and safety of a single 2 mg dose or 4 mg double dose of alteplase for 50 occluded chest ports using a unique instillation technique In home care settings, where patients may have limited access to interventional radiology, alteplase instillation through the Huber needle using a negative-pressure technique has been reported to clear thrombotic occlusions in about two-thirds of patients, also without serious adverse effects.11Journal of the Association for Vascular Access. The Use of Alteplase for Treatment of Occluded Central Venous Catheters in Home Care: Clinical Investigations
Newer thrombolytic agents like reteplase and tenecteplase have shown promising results in early studies, with clearance rates potentially higher than alteplase, but alteplase remains the most widely used and studied option. If thrombolytic therapy fails repeatedly, the occlusion may be mechanical rather than thrombotic, and imaging is usually the next step to check catheter position and rule out a kink or migration.
Reducing Pain During Port Access
Accessing a port means pushing a needle through the skin and into the silicone septum, which hurts. For patients who require frequent blood draws, the cumulative discomfort and anxiety can become a real barrier. Topical anesthetic cream applied to the skin over the port before the needle stick is the most common solution. A trial in children with cancer found that a topical lidocaine-prilocaine cream (commonly sold as EMLA) produced statistically significant decreases in pain scores compared to placebo during port access.12PubMed. Trial of a topically administered local anesthetic (EMLA cream) for pain relief during central venous port accesses in children with cancer
A more recent randomized controlled study in adults compared EMLA cream alone, a breathing technique called the Valsalva maneuver alone, and the combination of both during port needle insertion. The groups using EMLA, whether alone or combined with the Valsalva maneuver, reported the lowest pain scores and the highest comfort levels, both significantly better than the control group and the Valsalva-only group.13PubMed. Comparison of the effects of Valsalva maneuver, EMLA cream, and the combination of both in relieving pain of needle insertion on totally implantable access port: A randomized controlled study In practice, the cream needs about 30 to 60 minutes of skin contact under an occlusive dressing to work fully, so patients coming for a scheduled lab draw should apply it at home before leaving for the appointment. Vapocoolant sprays (cold sprays applied moments before the stick) are a quicker alternative when the cream was not applied in advance, though the evidence for their effectiveness on port access specifically is thinner.
For children in particular, combining topical anesthesia with distraction techniques, such as guided imagery, tablet screens, or child life specialist involvement, tends to reduce both pain and procedural anxiety more than either approach alone. Repeated painful port accesses in childhood can create lasting needle phobia, so investing in pain management during these draws pays off over the long term.
Removing the Needle Safely
After the blood draw is complete and the port has been flushed and locked, the Huber needle needs to come out. This sounds simple, but there is a small technical nuance worth knowing about. An observational experiment testing six different Huber needles found that five of the six allowed fluid to reflux back through the needle during withdrawal, with reflux volumes ranging up to 0.6 to 0.7 centimeters of visible fluid in the tubing, regardless of whether the extension tubing was clamped or unclamped.14Journal of the Association for Vascular Access. Observational Experiment of Catheter Reflux During Huber Needle Withdrawal In Two Countries
The concern with reflux is that blood drawn back into the catheter tip as the needle is removed can form a small clot at the end of the line, seeding an occlusion for the next access. The standard practice is to maintain positive pressure during needle removal: flush the last bit of saline while simultaneously withdrawing the needle, or clamp the extension tubing while still pushing the syringe plunger. The goal is to keep fluid flowing outward rather than allowing anything to suck back in. Some newer Huber needle designs incorporate anti-reflux valves, but as the study above showed, clamping alone does not reliably prevent reflux with most currently available needles. Maintaining active positive pressure during removal remains the more dependable approach.
When a Peripheral Stick Might Be Better
Not every lab test should be drawn through a port, even when one is available. Beyond the coagulation contamination issue already discussed, certain drug levels, particularly vancomycin and aminoglycosides that may have been infused through the port, can give falsely elevated results if drawn from the same line, even after a generous discard. Blood bank specimens for type and crossmatch also often require a peripheral draw by policy, since the consequences of a mislabeled or contaminated sample in transfusion medicine are severe.
Patients sometimes prefer that all blood be drawn through their port to avoid extra needle sticks, and this is reasonable for routine chemistry panels and complete blood counts. But when the lab order includes coagulation studies, therapeutic drug levels for medications given through the line, or blood bank specimens, a peripheral draw may give more reliable results and is worth the brief discomfort of an additional stick. Having a candid conversation about which tests genuinely require peripheral access helps patients understand the rationale rather than feeling like their port is being ignored for no reason.